Skip to content

Perioperative Outcome of Infraumbilical Versus a Modified Intraumbilical Direct Trocar Insertion

Perioperative Outcome of Infraumbilical Versus a Modified Intraumbilical Direct Trocar Insertion in Gynecologic Laparoscopy: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03988348
Enrollment
110
Registered
2019-06-17
Start date
2019-08-04
Completion date
2021-03-31
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease

Brief summary

Laparoscopic surgery is now a well-established alternative to open surgery for many gynecological disorders owing to its faster wound healing, shorter hospital stay, less postoperative pain, and better cosmetic results. Postoperative scar cosmoses is a critical issue for women, especially for young women. These scars may have negative impacts, such as psychological consequences. The symptoms associated with the wound, such as pain, tenderness, and itching, can be induced by the scars

Interventions

PROCEDUREinfraumbilical transverse incision

a 10 mm infraumbilical transverse incision will be done to allow trocar to be inserted without undue resistance from the skin so that the trocar will pass through the fascia and the peritoneum with ease

right sided curved longitudinal intraumbilical incision will be performed for initial intraperitoneal access

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* All women subjected to direct trocar application as a part of any gynecologic procedure performed

Exclusion criteria

* Verres needle insertion. * Patients with previous abdominal surgery and scar, * umbilical hernia, * previous laparoscopy or previous umbilical surgery, * burns in the umbilical region; * who have hyperpigmented skins.

Design outcomes

Primary

MeasureTime frameDescription
the mean difference in the duration of surgery30 minutescalculated from the onset of surgery till the end

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026